Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 129528
                    [Title] => Bayer withdrawing drug from market
                    [Summary] => Bayer is withdrawing its cholesterol-lowering drug with brand names Baycol/Lipobay (active ingredient: cerivastatin) from the world market, effective immediately except in Japan.


The pullout comes in the wake of increasing reports of side effects involving muscular weakness (rhabdomyolysis), especially in patients who have been treated concurrently with the active substance gemfibrozil despite a contraindication and warnings contained in the product information. 


Japan is unaffected by this move because gemfibrozil is not available there.


                    [DatePublished] => 2001-08-10 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => 
                )

        )

)

PHARMACEUTICALS BUSINESS GROUP

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 129528
                    [Title] => Bayer withdrawing drug from market
                    [Summary] => Bayer is withdrawing its cholesterol-lowering drug with brand names Baycol/Lipobay (active ingredient: cerivastatin) from the world market, effective immediately except in Japan.


The pullout comes in the wake of increasing reports of side effects involving muscular weakness (rhabdomyolysis), especially in patients who have been treated concurrently with the active substance gemfibrozil despite a contraindication and warnings contained in the product information. 


Japan is unaffected by this move because gemfibrozil is not available there.


                    [DatePublished] => 2001-08-10 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => 
                )

        )

)

abtest

Bayer withdrawing drug from market

August 10, 2001 - 12:00am

Bayer is withdrawing its cholesterol-lowering drug with brand names Baycol/Lipobay (active ingredient: cerivastatin) from the world market, effective immediately except in Japan. The pullout comes in the wake of...

Headlines